B-cell reconstitution for SCID: Should a conditioning regimen be used in SCID treatment?
- 1 April 2013
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 131 (4) , 994-1000
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant ChemotherapyJournal of Clinical Oncology, 2012
- The long quest for neonatal screening for severe combined immunodeficiencyJournal of Allergy and Clinical Immunology, 2012
- IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivoBlood, 2011
- B-cell function in severe combined immunodeficiency after stem cell or gene therapy: A reviewJournal of Allergy and Clinical Immunology, 2010
- Long-term Clinical Outcome of Patients with Severe Combined Immunodeficiency Who Received Related Donor Bone Marrow Transplants without Pretransplant Chemotherapy or Post-transplant GVHD ProphylaxisThe Journal of Pediatrics, 2009
- Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioningJournal of Allergy and Clinical Immunology, 2009
- Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimerasBlood, 2009
- Megadose CD34+ Cell Grafts Improve Recovery of T Cell Engraftment but not B Cell Immunity in Patients with Severe Combined Immunodeficiency Disease Undergoing Haplocompatible Nonmyeloablative TransplantationTransplantation and Cellular Therapy, 2008
- T-cell-depleted maternal bone marrow transplantation for siblings with X-linked severe combined immunodeficiencyThe Journal of Pediatrics, 1993
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986